VLDL: The key factors influencing the distribution of mitotane in patients with adrenocortical carcinoma

doi: 10.1016/j.jpha.2025.101252

• Xiangjie Dia^a,b,c , 
• Yixian Liua^a,b , 
• Jia You^a,b , 
• Yuchun Mena^a,b , 
• Zhenlei Wang^a,b , 
• Chao Zhou^d , 
• Ying Jin^a,b , 
• Yating Ge^a,b,e , 
• Yongji He^a,b , 
• Li Zheng^{a,b ,  ,} 

• a Cancer Center, Clinical Trial Center, West China Hospital, Sichuan University, Chengdu, 610041, China;

• b NMPA Key Laboratory for Clinical Research and Evaluation of Innovative Drug West China Hospital, Sichuan University, Chengdu, 610041, China;

• c Development and Related Diseases of Women and Children Key Laboratory of Sichuan Province, Sichuan University, Chengdu, 610041, China;

• d SCIEX China, Room 502, 1# building, No. 518, Fuquan North Road, Changning District, Shanghai 200335, PR China;

• e Department of Clinical Pharmacy and Pharmacy Administration, West China School of Pharmacy, Sichuan University, Chengdu, 610041, China